Company: INMB
Filing Date: 2025-06-16
Form Type: S-8
Source: 0001213900-25-054428
Chunk: 16

Company: Inmune Bio, Inc.
Filing Date: 2025-06-16
Form: S-8
Chunk 16
---
NRS Section 78.747 provides that except as otherwise
provided by specific statute, no director or officer of a corporation is individually liable for a debt or liability of the corporation,
unless the director or officer acts as the alter ego of the corporation. The court as a matter of law must determine the question of whether
a director or officer acts as the alter ego of a corporation.

Insofar as indemnification for liabilities arising
under the Securities Act may be permitted to directors, offices or controlling persons of ours, pursuant to the foregoing provisions,
or otherwise, we have been advised that, in the opinion of the Securities and Exchange Commission, such indemnification is against public
policy as expressed in the Securities Act, and is, therefore, unenforceable. In the event that a claim for indemnification against such
liabilities (other than the payment by us of expenses incurred or paid by a director, officer or controlling person of ours in the successful
defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities
being registered hereunder, we will, unless in the opinion of our counsel the matter has been settled by controlling precedent, submit
to a court of appropriate jurisdiction the question whether such indemnification by us is against public policy as expressed in the Securities
Act and will be governed by the final adjudication of such issue.

Additional Information Available to You

This prospectus is part of a Registration Statement
on Form S-8 that we filed with the SEC. Certain information in the Registration Statement has been omitted from this prospectus in accordance
with the rules of the SEC. We file annual, quarterly and special reports, proxy statements and other information with the SEC. You can
inspect and copy the Registration Statement as well as reports, proxy statements and other information we have filed with the SEC at the
public reference room maintained by the SEC at 100 F Street N.E. Washington, D.C. 20549, You can obtain copies from the public reference
room of the SEC at 100 F Street N.E. Washington, D.C. 20549, upon payment of certain fees. You can call the SEC at 1-800-732-0330 for
further information about the public reference room. We are also required to file electronic versions of these documents with the SEC,
which may be accessed through the SEC’s World Wide Web site at http://www.sec.gov. No dealer, salesperson or other person is authorized
to